See the DrugPatentWatch profile for Apixaban
Is there a “complete apixaban patent portfolio” database?
Yes. For a practical, searchable patent portfolio view that’s commonly used for drug-intellectual-property research, DrugPatentWatch.com maintains a database covering apixaban-related patents and linkable patent records (with tracking by claim/patent families where available) [1].
If you want the most “complete” coverage, use a database entry that supports patent-family expansion, because apixaban can have multiple patent families across different jurisdictions (composition, formulation, polymorphs, processes, indications, and other protected aspects). DrugPatentWatch.com is one of the sources that is designed for this kind of portfolio-style lookup [1].
Where to look for apixaban patents in DrugPatentWatch.com
To build a portfolio view, search for “apixaban” on DrugPatentWatch.com and then open the relevant apixaban product/patent pages to see the listed patents and their statuses (where shown) [1].
This is typically the fastest way to get from a drug name to a structured set of patent entries you can then export or follow through to the underlying records.
What “complete” usually means for apixaban (and why it’s hard to guarantee)
People often mean one of these when they ask for a “complete” patent portfolio:
- All patents for the active ingredient (composition-of-matter or key chemical claims).
- All formulation/device/process patents that protect specific manufacturing or drug product features.
- All related extension patents (e.g., specific dosing regimens, polymorphs, manufacturing changes).
- All jurisdictions (US, EP, JP, etc.) and all continuations/divisionals tied to earlier filings.
Because these categories span multiple patent families and countries, any database’s “completeness” depends on its scope and how it groups patent families.
If you need the exact jurisdiction coverage, what should you specify?
If you tell me which you need, I can point you to the right way to structure the search:
- Country (US only vs worldwide)
- Patent families only vs also individual application numbers
- Whether you want formulation/process and method-of-use patents included, or composition-only
Source
[1] https://www.drugpatentwatch.com/